News

Filter

26 to 35 of 96659 results

Pfizer beats sales and earnings forecast for the third quarter

Pfizer beats sales and earnings forecast for the third quarter

28-10-2014

US pharma giant Pfizer has beaten the forecasts for both its sales and its earnings for the third quarter…

FinancialLyricaPfizerPharmaceuticalUSAViagra

Bristol-Myers enters option deal to acquire F-star Alpha and FS102

28-10-2014

US pharma major Bristol-Myers Squibb has entered into an agreement that provides it with the exclusive…

BiotechnologyBristol-Myers SquibbF-star AlphaFS102Mergers & AcquisitionsOncology

Recordati reports strong earnings growth for first nine months of 2014

28-10-2014

Italian pharma company Recordati has reported a strong set of financials for the first three-quarters…

FinancialPharmaceuticalRecordati

Russian approval for Norgine/Takeda’s MoviPrep

28-10-2014

Netherlands-headquartered independent drugmaker Norgine says that its partner, Japan’s largest pharma…

Gastro-intestinalsMoviPrepNorginePharmaceuticalRegulationRussiaTakeda Pharmaceutical

Bristol-Myers Squibb signs deal with Korean company OliPass

Bristol-Myers Squibb signs deal with Korean company OliPass

28-10-2014

Privately-held Korean biopharmaceutical company OliPass has announced a worldwide strategic alliance…

Bristol-Myers SquibbOliPassPharmaceuticalResearchRest of the World

Sarepta receives new FDA guidance on data needed for eteplirsen's NDA in Duchenne Muscular Dystrophy

Sarepta receives new FDA guidance on data needed for eteplirsen's NDA in Duchenne Muscular Dystrophy

28-10-2014

Rare and infectious disease specialist Sarepta provided an update on its discussions with the US Food…

CNS DiseaseseteplirsenPharmaceuticalRegulationSarepta TherapeuticsUSA

Elderly UK patients with rare blood cancer receive substandard care

Elderly UK patients with rare blood cancer receive substandard care

28-10-2014

Elderly people in the UK with Myelodysplastic Syndromes (MDS), a rare form of blood cancer, are not being…

Celgene Corp.HealthcareOncologyPharmaceuticalResearchUK

Novartis’ strong third-qtr boosted by sale of Idenix stake

Novartis’ strong third-qtr boosted by sale of Idenix stake

28-10-2014

Swiss pharma major Novartis this morning reported that sales for the third quarter of 2014 rose 4% to…

AlconFinancialNovartisPharmaceuticalSandozSwitzerland

Sanofi's third quarter figures are on track but shares fall on diabetes price competition warning

Sanofi's third quarter figures are on track but shares fall on diabetes price competition warning

28-10-2014

French drug major Sanofi’s third-quarter earnings are in focus, but the company’s shares have plummeted…

FinancialFranceGenzymePharmaceuticalSanofi

26 to 35 of 96659 results

Parexel

Parexel

Back to top